Global Cancer Immunotherapy Market By Technology (Monoclonal Antibodies, Cytokines & Immunomodulators), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer), End User (Hospitals, Clinics)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Cancer Immunotherapy Market
Market Report Description
The Global Cancer Immunotherapy Market size is expected to reach $128.3 billion by 2024, rising at a market growth of 14.3% CAGR during the forecast period.
Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.
Global Cancer Immunotherapy Market Size
Based on technology, the Cancer Immunotherapy Market Size is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology. Based on application, the market is segmented into Lung cancer, Breast cancer, Colorectal, Prostate cancer, Head & Neck cancer and other application. Based on end user the market is segmented into Hospitals, Clinics and other end user.. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Global Cancer Immunotherapy Market Share
The Cancer Immunotherapy Market Analysis report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche LtdA
Scope of the Study
Market Segmentation:
By Technology
- Monoclonal Antibodies,
- Cytokines & Immunomodulators
- Other technology
By Application
- Lung cancer
- Breast cancer
- Colorectal
- Prostate cancer
- Head & Neck cancer
- Other application.
By End User
- Hospitals
- Clinics
- Other End User
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- AstraZeneca
- Amgen Inc.
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Bayer Ag
- Immunomedics Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
Unique Offerings from KBV Research
- Exhaustive coverage of Cancer Immunotherapy Market Size
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Related Reports:
North America Cancer Immunotherapy Market (2018-2024)
Europe Cancer Immunotherapy Market (2018-2024)